Key result
Plasma adiponectin levels were independently associated with the presence of coronary artery disease in patients with metabolic syndrome (OR 0.86; 95% CI 0.78-0.94; P=0.001).
Why the study?
Are plasma adiponectin levels associated with the presence and severity of coronary artery disease in patients with metabolic syndrome?
Cross-Sectional (n=167)
Are plasma adiponectin levels associated with the presence and severity of coronary artery disease in patients with metabolic syndrome?
Odds Ratio: 0.86 (95% CI 0.78–0.94)
p-value: p=0.001
Lower plasma adiponectin levels are independently associated with the presence and angiographic severity of coronary artery disease in patients with metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Lower adiponectin was associated with CAD in metabolic syndrome; hypothesis-generating and should not yet change risk assessment.
Selçuk et al. (2008) conducted a cross-sectional in Metabolic syndrome (n=167). Plasma adiponectin levels was evaluated on Presence of coronary artery disease (CAD) (OR 0.86, 95% CI 0.78-0.94, p=0.001). Plasma adiponectin levels were independently associated with the presence of coronary artery disease in patients with metabolic syndrome (OR 0.86; 95% CI 0.78-0.94; P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: